Marie Gourdeau
Overview
Explore the profile of Marie Gourdeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cote F, Bestman-Smith J, Gourdeau M, Simpson S, Hamelin M, Carbonneau J, et al.
J Assoc Med Microbiol Infect Dis Can
. 2022 Nov;
7(3):283-291.
PMID: 36337604
Background: COVID-19 is usually a time-limited disease. However, prolonged infections and reinfections can occur among immunocompromised patients. It can be difficult to distinguish a prolonged infection from a new one,...
2.
DeLisle G, Quach C, Domingo M, Boudreault A, Gourdeau M, Bernatchez H, et al.
J Antimicrob Chemother
. 2016 Aug;
71(12):3562-3567.
PMID: 27494927
Objectives: Empirical treatment of uncomplicated urinary tract infections (UTIs) in women should be based on local susceptibility data. We aimed to generate regional and provincial cumulative antibiograms combining data from...
3.
Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M
Antimicrob Agents Chemother
. 2011 Nov;
56(2):639-46.
PMID: 22106208
Seasonal variations in Clostridium difficile-associated diarrhea (CDAD), with a higher incidence occurring during winter months, have been reported. Although winter epidemics of respiratory viruses may be temporally associated with an...
4.
Vezina D, Trepanier C, Lessard M, Gourdeau M, Tremblay C, Guidoin R
Anesthesiology
. 2004 Jun;
101(1):104-9.
PMID: 15220778
Background: The use of breathing filters (BFs) has been recommended to protect the anesthesia apparatus in proven or suspected cases of tuberculosis. Some investigators have also suggested the use of...
5.
Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselin L, Rochette L
CMAJ
. 2004 Feb;
170(4):469-73.
PMID: 14970093
Background: The optimal duration of antibiotic therapy in older patients with uncomplicated urinary tract infection (UTI) is still a matter of debate. The aim of this randomized controlled double-blind noninferiority...
6.
Zoutman D, Ford B, Bryce E, Gourdeau M, Hebert G, Henderson E, et al.
Am J Infect Control
. 2003 Jul;
31(5):266-72; discussion 272-3.
PMID: 12888761
Background: Nosocomial infections and antibiotic-resistant pathogens cause significant morbidity, mortality, and economic costs. The infection surveillance and control resources and activities in Canadian acute care hospitals had not been assessed...
7.
Gershon A, de Azavedo J, McGeer A, Ostrowska K, Church D, Hoban D, et al.
Antimicrob Agents Chemother
. 2002 Apr;
46(5):1553-6.
PMID: 11959597
The rates of nonsusceptibility to penicillin, erythromycin, and clindamycin of 191 blood culture isolates of viridans group streptococci collected from across Canada in 2000 were 36, 42, and 10%, respectively....
8.
Miller M, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M
Infect Control Hosp Epidemiol
. 2002 Mar;
23(3):137-40.
PMID: 11918118
Objective: To assess the healthcare burden, morbidity, and mortality of nosocomial Clostridium difficile-associated diarrhea (N-CDAD) in Canadian hospitals. Design: Laboratory-based prevalence study. Setting: Nineteen acute-care Canadian hospitals belonging to the...